Three papers in this issue find that the neuropeptide #CGRP limits type 2 inflammation by suppressing #ILC2 responses: O'Shea &co https://t.co/xRPVTcK7Wg Xavier &co: https://t.co/mZrpTTP0Vb Kuchroo &co: https://t.co/TZ4T4eck5Q Preview by Moro &co: https://t.co/uNyJ3A65og